April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Large Deletions of the KCNV2 Gene in Patients With Cone Dystrophy and Supernormal Rod Response
Author Affiliations & Notes
  • B. Wissinger
    Molecular Genetics Laboratory,
    Centre for Ophthalmology, Tuebingen, Germany
  • S. Schaich
    Molecular Genetics Laboratory,
    Centre for Ophthalmology, Tuebingen, Germany
  • C. Wolf
    Molecular Genetics Laboratory,
    Centre for Ophthalmology, Tuebingen, Germany
  • H. Jägle
    University Eye Hospital,
    Centre for Ophthalmology, Tuebingen, Germany
  • F. Cremers
    Radboud University Nijmegen Medical Centre, Department of Human Genetics, Nijmegen, The Netherlands
  • H. Dollfus
    Medical Genetics Laboratory, University of Strasbourg, Strasbourg, France
  • B. Varsanyi
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • T. Rosenberg
    Gordon Norrie Centre for Genetic Eye Diseases, National Eye Clinic - Kennedy Center, Hellerup, Denmark
  • E. Zrenner
    University Eye Hospital,
    Centre for Ophthalmology, Tuebingen, Germany
  • S. Kohl
    Molecular Genetics Laboratory,
    Centre for Ophthalmology, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  B. Wissinger, None; S. Schaich, None; C. Wolf, None; H. Jägle, None; F. Cremers, None; H. Dollfus, None; B. Varsanyi, None; T. Rosenberg, None; E. Zrenner, None; S. Kohl, None.
  • Footnotes
    Support  KFO134-KO2176/1-2
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3743. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Wissinger, S. Schaich, C. Wolf, H. Jägle, F. Cremers, H. Dollfus, B. Varsanyi, T. Rosenberg, E. Zrenner, S. Kohl; Large Deletions of the KCNV2 Gene in Patients With Cone Dystrophy and Supernormal Rod Response. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3743.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the molecular genetics and disease mechanism of Cone Dystrophy with Supernormal Rod Response (CDSRR) that is linked to the KCNV2 gene

Methods: : The KCNV2 gene and flanking SNPs were analyzed by DNA sequencing. Gene dosage analyses were carried out by means of TaqMan probe based realtime PCR and Nimblegen CGH array technology. Deletion junction fragments were obtained from Long Distance (LD) PCR amplifications and breakpoints covered by DNA sequencing.

Results: : In a screen for KCNV2 mutations in patients with CDSRR and similar type of retinal disorders we found two unrelated subjects with a homozygous deletion covering ~ 9 kb of genomic DNA sequence including most parts of exon 1 and intron 1. Moreover we observed four independent patients with apparent homozygous point mutations that failed to segregate concordantly in the nuclear family. Using quantitative realtime PCR we could show a decrease in KCNV2 gene dosage in all of those patients. Applying loss of heterozygosity and segregation analysis of flanking SNP and microsatellite markers we were able to narrow the extent of the deletions in three subjects, that finally enabled amplification and sequencing of deletion junction fragments in two of the subjects. A further patient was investigated applying Nimblegen CGH arrays which allowed the identification of a ~ 70 kb whole gene deletion.

Conclusions: : Based on our screening data we found larger deletions in 6 of 27 patients with KCNV2 mutations indicating that such genomic rearrangements have to be taken into consideration in the genetic diagnostics of CDSRR. Our data also demonstrate that a complete loss of KCNV2 is a common pathomechanism in CDSRR.

Keywords: gene screening • retinal degenerations: hereditary • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×